Found: 30
Select item for more details and to access through your institution.
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0
- By:
- Publication type:
- Article
A Contemporary Clinicopathologic Analysis of Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral, or Bladder Carcinoma.
- Published in:
- International Journal of Surgical Pathology, 2022, v. 30, n. 1, p. 15, doi. 10.1177/10668969211032481
- By:
- Publication type:
- Article
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.701345
- By:
- Publication type:
- Article
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials.
- Published in:
- Oncology, 2018, v. 95, n. 3, p. 138, doi. 10.1159/000488763
- By:
- Publication type:
- Article
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.779915
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 239, doi. 10.1093/oncolo/oyac236
- By:
- Publication type:
- Article
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 462, doi. 10.1093/oncolo/oyac061
- By:
- Publication type:
- Article
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1017, doi. 10.1002/onco.13922
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e484, doi. 10.1634/theoncologist.2019-0578
- By:
- Publication type:
- Article
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e528, doi. 10.1634/theoncologist.2019-0751
- By:
- Publication type:
- Article
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2752, doi. 10.1002/cam4.2932
- By:
- Publication type:
- Article
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.949400
- By:
- Publication type:
- Article
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1642, doi. 10.1002/cncr.35179
- By:
- Publication type:
- Article
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
- By:
- Publication type:
- Article
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 966, doi. 10.1002/cncr.34016
- By:
- Publication type:
- Article
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.
- Published in:
- BJU International, 2014, v. 113, n. 6, p. 871, doi. 10.1111/bju.12450
- By:
- Publication type:
- Article
Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920982859
- By:
- Publication type:
- Article
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.
- Published in:
- Frontiers in Health Services, 2024, p. 1, doi. 10.3389/frhs.2024.1254294
- By:
- Publication type:
- Article
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5721, doi. 10.3390/cancers15245721
- By:
- Publication type:
- Article
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [ 68 Ga]Ga DOTATATE PET-CT.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6039, doi. 10.3390/cancers14246039
- By:
- Publication type:
- Article
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2867, doi. 10.3390/cancers14122867
- By:
- Publication type:
- Article
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
- Published in:
- International Journal of Urology, 2015, v. 22, n. 3, p. 264, doi. 10.1111/iju.12672
- By:
- Publication type:
- Article
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 10, p. 1312, doi. 10.1093/neuonc/nov093
- By:
- Publication type:
- Article